SIRT1 and acute lymphoblastic leukemia: A recent CRISPR/Cas9 screen in B-ALL has identified a class III HDAC, SIRT1, overexpression in KMT2A rearrangements increases panobinostat sensitivity by mitochondrial activity initiation [35].